Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7574678

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
554,909,000 JPY
647,576,000 JPY
448,082,000 JPY
Ordinary profit (loss)
-67,637,000 JPY
-243,472,000 JPY
-232,900,000 JPY
Net assets
1,291,917,000 JPY
1,368,348,000 JPY
1,383,600,000 JPY
Total assets
1,629,938,000 JPY
1,705,338,000 JPY
1,715,442,000 JPY
Basic earnings (loss) per share
-8.20
6.41
-27.78
-26.14
-4.74
Diluted earnings per share
Equity-to-asset ratio
0.793 xbrli:pure
0.802 xbrli:pure
0.807 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.